Anthropic Faces Drug Development Reality Check in Filing
In its recent financial filings, Anthropic faces drug discovery realities that contrast sharply with its previously ambitious public narrative. For months, executive messaging emphasized the transformative power of artificial intelligence in life sciences, with leadership publicly suggesting that foundation models could compress a millennium of biological progress into a single decade. However, official regulatory disclosures … Read more